الأبحاث

internalContent

​​​​​​​

    الإسم نبذة معاينة
    All-cause mortality among diabetic foot patients and related risk factors in Saudi ArabiaAlthough Diabetes mellitus is a major public health problem in the Middle East and North Africa (MENA) region with high rates of diabetic foot complications, there are only limited data concerning mortality among such a high risk group. Therefore, the main aim of the current study was to assess all-cause mortality and its related predictors among diabetic patients with and without diabetic foot complications
    Australian National Diabetes StrategyThe Australian National Diabetes Strategy aims to outline Australia’s national response to diabetes and inform how existing limited health care resources can be better coordinated and targeted across all levels of government. This Strategy identifies the most effective and appropriate interventions to reduce the impact of diabetes in the community and lead the way internationally in diabetes prevention, management and research
    Burden of Diabetes Mellitus in Saudi ArabiaDiabetes Mellitus (DM) is one of the fastest-growing health problem in the world, which is now reaching to epidemic proportion in some countries. It is mainly due to consequence of life-style as lack of exercise, unhealthy diet, obesity and overweight. Over the past four decades major socio-economic changes have occurred in Saudi Arabia. The growth and prosperity have brought pronounced changes in the lifestyle of the people. Most notably, eating habits are less healthful and the level of physical activity has declined. There is increased consumption of fast foods and sugar-dense beverages (e.g., sodas)
    Concomitant Macro and Microvascular Complications in Diabetic Nephropathy To determine the prevalence of concomitant microvascular and macrovascular complications of diabetic nephropathy we retrospectively reviewed the medical records of all 1,952 type 2 diabetic patients followed-up at Security Forces Hospital, Riyadh, Saudi Arabia from January 1989 to December 2004
    Cost of Diabetes in the Kingdom of Saudi Arabia, 2014The Kingdom of Saudi Arabia (KSA) has made tremendous improvements in its health system in a short period of time due to extensive investments from oil revenues [1,2]. In 2010, the Saudi Ministry of Health (MOH) housed 250,000 personnel, including 31,516 physicians and 75,978 nurses, and operated 249 hospitals with 34,000 beds. It is responsible for 60% of healthcare services, with the remaining 40% managed by a number of semi-public organizations and the private sector
    Diabetes Mellitus in Saudi Arabia: A Review of the Recent Literature Diabetes mellitus (DM) is rapidly becoming one of the main health issues among humans in the 21st century and the number of patients is steadily increasing, globally, both in the developed and developing countries. It is a noninfectious chronic disease caused by the inability of the pancreas to effectively produce enough insulin or when the body in unable to properly use the insulin produced by it
    Diabetic Foot Complications and Their Risk Factors from a Large Retrospective Cohort StudyDiabetic foot complications are contributing to both mortality and morbidity among the diabetic population leading to substantial physical, physiological and financial burden for the patients and community at large. It is estimated that 24.4% of the total health care expenditure among diabetic population is related to foot complications [1] and the total cost of treating diabetic foot complications is approaching 11 billion USD in USA [2] and 456 million USD in UK
    Economic costs of diabetes in Saudi ArabiaDiabetes imposes a large economic burden on the individual, national healthcare systems, and countries.[1‑5] Healthcare expenditures due to diabetes account for 11% of the total healthcare expenditures in the world in 2011.[6] Estimated global healthcare expenditures to treat diabetes and prevent complications totaled $465 billion in 2011. By 2030, this number is projected to exceed some $595 billion
    IDF DIABETES ATLAS Eighth edition 2017Diabetes in all forms imposes an unacceptably high human, social and economic cost on countries at all income levels. Since the first edition in 2000, the IDF Diabetes Atlas has been reporting the results and analysis of the continuing growth in rates of diabetes incidence and prevalence worldwide
    Prevalence of type 1 diabetes mellitus in Saudi Arabian children and adolescentsA nationwide Saudi Arabian project was conducted in the years 2001-2007 with the objective of establishing national growth charts, and defining the prevalence of some chronic childhood diseases such as diabetes mellitus. The 14,000 households were randomly selected based on a recent population statistic. The questionnaire used included demographic data and evidence of diabetes mellitus. The prevalence was estimated and expressed per 100,000. Breakdown of this figure per age and region was carried out
    Status of the diabetes epidemic in the Kingdom of Saudi Arabia, 2013From 1990 to 2010, the number of deaths attributable to type 2 diabetes doubled from 650,000 to 1.3 million worldwide (Lozano et al. 2012). Various epidemiological studies have found that the increase in diabetes prevalence is correlated with the global urbanization: a trend toward
    Type 2 Diabetes Mellitus in Saudi Arabia: Major Challenges and Possible Solutions Diabetes Mellitus (DM) has been dubbed the 21st century’s prime healthcare challenge across the globe, by the World Health Organization (WHO) and the International Diabetes Federation (IDF). Diabetes related complications and mortality also generate social and economic challenges that seriously impact the lives of individuals, families, businesses, and the entire society